Covaxin vaccine on human trial

AIIMS panel gives nod for human clinical trials of indigenous vaccine candidate COVAXIN

The AIIMS Ethics Committee has given its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate COVAXIN. AIIMS is likely to begin the exercise by enrolling healthy volunteers from Monday.

AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research for conducting phase I and II human trials of COVAXIN. In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.

Healthy volunteers having no comorbid conditions and without a history of COVID-19, aged more than 18 years and less than 55 years, would be eligible to participate in the randomised, double-blind, placebo-controlled clinical trial

Published by Naresh Sagar

Mentor MSME, Motivator, Media Event Org, Management fiscal & Water management.Social Media branding,Internet broadcasters,Propunder of Indian Philosophy

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: